Table of Content
1 Viral Vaccines Market Introduction and Overview
1.1 Viral Vaccines Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Viral Vaccines Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Viral Vaccines Revenue and Market Share by Type
3 Global Viral Vaccines Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Viral Vaccines Revenue Market Share by Application (2019-2024)
4 Global Market Growth Trends Analysis
4.1 Global Viral Vaccines Market Size (2019-2024)
4.2 Viral Vaccines Growth Trends Analysis by Regions
4.2.1 Viral Vaccines Market Size by Regions: 2019 VS 2024 VS 2030
4.2.2 Viral Vaccines Historic Revenue Market Size by Regions (2019-2024)
4.2.3 North America Viral Vaccines Market Size (2019-2024)
4.2.4 Europe Viral Vaccines Market Size (2019-2024)
4.2.5 Asia-Pacific Viral Vaccines Market Size (2019-2024)
4.2.6 Latin America Viral Vaccines Market Size (2019-2024)
4.2.7 Middle East & Africa Viral Vaccines Market Size (2019-2024)
5 North America
5.1 North America Viral Vaccines Revenue by Countries
5.1.1 North America Viral Vaccines Revenue by Countries (2019-2024)
5.2 North America Viral Vaccines Revenue by Types
5.3 North America Viral Vaccines Revenue by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Viral Vaccines Revenue by Countries
6.1.1 Asia Pacific Viral Vaccines Revenue by Countries (2019-2024)
6.2 Asia Pacific Viral Vaccines Revenue by Types
6.3 Asia Pacific Viral Vaccines Revenue by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Viral Vaccines Revenue by Countries
7.1.1 Europe Viral Vaccines Revenue by Countries (2019-2024)
7.2 Europe Viral Vaccines Revenue by Types
7.3 Europe Viral Vaccines Revenue by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Viral Vaccines Revenue by Countries
8.1.1 Latin America Viral Vaccines Revenue by Countries (2019-2024)
8.2 Latin America Viral Vaccines Revenue by Types
8.3 Latin America Viral Vaccines Revenue by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Viral Vaccines Revenue by Countries
9.1.1 Middle East & Africa Viral Vaccines Revenue by Countries (2019-2024)
9.2 Middle East & Africa Viral Vaccines Revenue by Types
9.3 Middle East & Africa Viral Vaccines Revenue by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Viral Vaccines Market Competition, by Players
10.1 Global Viral Vaccines Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Viral Vaccines Players Market Share in 2023
10.2.2 Top 6 Viral Vaccines Players Market Share in 2023
10.2.3 Market Competition Trend
10.3 Viral Vaccines Players Head Office, Business Provided
10.4 Viral Vaccines Mergers & Acquisitions
10.5 Viral Vaccines New Entrants and Expansion Plans
11 Players Profiles11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Profile
11.1.2 Viral Vaccines Product Overview
11.1.3 Merck & Co., Inc. Viral Vaccines Market Performance (2019-2024)
11.1.4 Merck & Co., Inc. Business Overview
11.1.5 Recent Developments and Plans
11.2 Novartis, Inc.
11.2.1 Novartis, Inc. Company Profile
11.2.2 Viral Vaccines Product Overview
11.2.3 Novartis, Inc. Viral Vaccines Market Performance (2019-2024)
11.2.4 Novartis, Inc. Business Overview
11.2.5 Recent Developments and Plans
11.3 Emergent BioSolutions Inc.
11.3.1 Emergent BioSolutions Inc. Company Profile
11.3.2 Viral Vaccines Product Overview
11.3.3 Emergent BioSolutions Inc. Viral Vaccines Market Performance (2019-2024)
11.3.4 Emergent BioSolutions Inc. Business Overview
11.3.5 Recent Developments and Plans
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Profile
11.4.2 Viral Vaccines Product Overview
11.4.3 GlaxoSmithKline plc Viral Vaccines Market Performance (2019-2024)
11.4.4 GlaxoSmithKline plc Business Overview
11.4.5 Recent Developments and Plans
11.5 Serum institute of India Private Limited
11.5.1 Serum institute of India Private Limited Company Profile
11.5.2 Viral Vaccines Product Overview
11.5.3 Serum institute of India Private Limited Viral Vaccines Market Performance (2019-2024)
11.5.4 Serum institute of India Private Limited Business Overview
11.5.5 Recent Developments and Plans
11.6 Seqirus (CSL Limited)
11.6.1 Seqirus (CSL Limited) Company Profile
11.6.2 Viral Vaccines Product Overview
11.6.3 Seqirus (CSL Limited) Viral Vaccines Market Performance (2019-2024)
11.6.4 Seqirus (CSL Limited) Business Overview
11.6.5 Recent Developments and Plans
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Profile
11.7.2 Viral Vaccines Product Overview
11.7.3 Pfizer, Inc. Viral Vaccines Market Performance (2019-2024)
11.7.4 Pfizer, Inc. Business Overview
11.7.5 Recent Developments and Plans
11.8 Sanofi
11.8.1 Sanofi Company Profile
11.8.2 Viral Vaccines Product Overview
11.8.3 Sanofi Viral Vaccines Market Performance (2019-2024)
11.8.4 Sanofi Business Overview
11.8.5 Recent Developments and Plans
11.9 AstraZeneca plc
11.9.1 AstraZeneca plc Company Profile
11.9.2 Viral Vaccines Product Overview
11.9.3 AstraZeneca plc Viral Vaccines Market Performance (2019-2024)
11.9.4 AstraZeneca plc Business Overview
11.9.5 Recent Developments and Plans
11.10 Novavax, Inc.
11.10.1 Novavax, Inc. Company Profile
11.10.2 Viral Vaccines Product Overview
11.10.3 Novavax, Inc. Viral Vaccines Market Performance (2019-2024)
11.10.4 Novavax, Inc. Business Overview
11.10.5 Recent Developments and Plans
12 Global Viral Vaccines Forecast Market Analysis by Type
12.1 Global Viral Vaccines Revenue Market Forecast by Type (2024-2030)
13 Global Viral Vaccines Forecast Market Analysis by Application
13.1 Viral Vaccines Revenue Market Forecast by Application (2024-2030)
14 Global Market Growth Forecast Analysis
14.1 Global Viral Vaccines Forecast Market Size (2024-2030)
14.2 Viral Vaccines Growth Trends Forecast Analysis by Regions
14.2.1 Viral Vaccines Revenue Forecast Market Size by Regions (2024-2030)
14.2.2 North America Viral Vaccines Forecast Market Size (2024-2030)
14.2.3 Europe Viral Vaccines Forecast Market Size (2024-2030)
14.2.4 Asia-Pacific Viral Vaccines Forecast Market Size (2024-2030)
14.2.5 Latin America Viral Vaccines Forecast Market Size (2024-2030)
14.2.6 Middle East & Africa Viral Vaccines Forecast Market Size (2024-2030)
15 Viral Vaccines Industry Dynamic Analysis
15.1 Viral Vaccines Market Trends Analysis
15.2 Viral Vaccines Market Drivers Analysis
15.3 Viral Vaccines Market Challenges Analysis
15.4 Viral Vaccines Market Restraints Analysis
